This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Russell Richard Lee Hamer: Innovator in Pharmaceutical Chemistry
Introduction
Russell Richard Lee Hamer is a notable inventor based in Lebanon, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Hamer holds a patent for "1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds." This patent discloses novel 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols, intermediates, and processes for their preparation. The methods outlined in the patent aim to reduce inflammation and cell proliferation, relieve memory dysfunction, and inhibit bacterial and fungal growth.
Career Highlights
Hamer is associated with Aventis Pharmaceuticals Inc., where he has been instrumental in advancing research and development in pharmaceutical products. His work has contributed to the understanding and creation of new therapeutic agents.
Collaborations
Throughout his career, Hamer has collaborated with esteemed colleagues, including John J Tegeler and Barbara S Rauckman. These collaborations have fostered innovation and enhanced the impact of their collective research efforts.
Conclusion
Russell Richard Lee Hamer's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to influence the development of new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile